{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:10:58Z","timestamp":1776071458928,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd002904","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T00:00:00Z","timestamp":1082332800000}}],"reference-count":77,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002904.pub2","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:20:52Z","timestamp":1082712052000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glucocorticosteroids for viral hepatitis C"],"prefix":"10.1002","volume":"2009","author":[{"given":"Jesper","family":"Brok","sequence":"first","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Thyge","family":"Mellerup","sequence":"additional","affiliation":[{"name":"Hegnsvej 127 Naerum Denmark DK-2850"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Krogsgaard","sequence":"additional","affiliation":[{"name":"H:S Hvidovre University Hospital 447; PhaseOneTrials A\/S; Ketteg\u00e5rds all\u00e9 Hvidovre Denmark DK-2650"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,4,19]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD002904.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep.510230502","article-title":"A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C","volume":"23","author":"Chayama","year":"1996","journal-title":"Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD002904.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type 2 mixed cryoblobulinemia","volume":"84","author":"Dammacco","year":"1994","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD002904.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(00)80170-1","article-title":"Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C","volume":"33","author":"Guilera","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0005|cit4","first-page":"3247","article-title":"Prednisolone withdrawel followed by recombinant alfa-interferon in chronic non-A, non-B hepatitis","volume":"26 Suppl","author":"Liaw","year":"1991","journal-title":"Gastroenterologia Japonica"},{"issue":"1","key":"10.1002\/14651858.CD002904.pub2-BIB0004|cit5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0676.1993.tb00604.x","article-title":"Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B hepatitis","volume":"13","author":"Liaw","year":"1993","journal-title":"Liver"},{"issue":"8","key":"10.1002\/14651858.CD002904.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S1590-8658(00)80335-7","article-title":"Interferon versus steroids in patients with hepatitis C virus associated cryoglobulinaemic glomerulonephritis","volume":"32","author":"Mazzaro","year":"2000","journal-title":"Digestive and Liver Disease"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004836-200102000-00008","article-title":"Prednisone withdrawel followed by interferon alpha for treatment of chronic hepatitis C infection","volume":"32","author":"McHutchison","year":"2001","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0008|cit8","first-page":"87A","article-title":"Pulse corticosteroids therapy increases viremia (HCV RNA) in patients with chronic HCV infection [abstract]","volume":"18 (4 pt 2)","author":"McHutchison","year":"1993","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0009|cit9","first-page":"150A","article-title":"Lymphoid alpha-IFN plus prednisone treatment of anti-HCV positive chronic hepatitis [abstract]","volume":"18 Suppl (1)","author":"Mondazzi","year":"1993","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD002904.pub2-BIB0010|cit10","first-page":"1783A","article-title":"Effects of short-term corticosteroid therapy in patients with chronic non-A, non-B hepatitis [abstract]","volume":"92","author":"Stokes","year":"1987","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0676.1986.tb01070.x","article-title":"Steroids in chronic B-hepatitis. A randomised, double-blind, multinational trial on the effect of low-dose, long-term treatment on survival","volume":"6","author":"Anonymous","year":"1986","journal-title":"Liver"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.1993.tb00106.x","article-title":"Prednisolone withdrawal followed by lymphoblastoid interferon alpa in the therapy of adult patients with presumed childhood acquired chronic hepatitis B virus infection","volume":"7","author":"Brook","year":"1993","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"158","key":"10.1002\/14651858.CD002904.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"The Quarterly Journal of Medicine"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0014|cit14","first-page":"320","article-title":"Treatment of children with chronic hepatitis B with a combinations of steroids and human lymphobastoid interferon","volume":"7 Suppl","author":"Giacchino","year":"1988","journal-title":"Chemioterapia"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-0676.1995.tb00661.x","article-title":"Dual-centre, double-blind, randomsed trial of lymphoblasoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B","volume":"15","author":"Giacchino","year":"1995","journal-title":"Liver"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.510230407","article-title":"Lymphoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B","volume":"23","author":"Gregorio","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.1840060204","article-title":"Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis","volume":"6","author":"Hanson","year":"1986","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD002904.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-104-1-12","article-title":"A short course of prednisolone in chronic type B hepatitis. Report of a randomised double-blind, placebo-controlled trial","volume":"104","author":"Hoofnagle","year":"1986","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD002904.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0168-8278(96)80282-0","article-title":"Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B","volume":"25","author":"Krogsgaard","year":"1996","journal-title":"Journal of Hepatology"},{"issue":"39","key":"10.1002\/14651858.CD002904.pub2-BIB0020|cit20","first-page":"5657","article-title":"Pretreatment with prednisolone enhance the effect of human lymphoblastoid interferon in chronic hepatitis B","volume":"160","author":"Krogsgaard","year":"1998","journal-title":"Ugeskrift for Laeger"},{"issue":"7","key":"10.1002\/14651858.CD002904.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM198102123040702","article-title":"Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis","volume":"304","author":"Lam","year":"1981","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02990568","article-title":"Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of type 2 mixed essential cryoglobulinemia","volume":"12","author":"Lauta","year":"1995","journal-title":"Medical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0168-8278(91)90946-9","article-title":"A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B","volume":"12","author":"Lee","year":"1991","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0168-8278(05)80055-8","article-title":"Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid pretreatment on the treatment of chronic type B hepatitis in Asians","volume":"20","author":"Liaw","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"85 (2A)","key":"10.1002\/14651858.CD002904.pub2-BIB0025|cit25","first-page":"147","article-title":"Treatment of chronic type B hepatitis in Southeast Asia","volume":"29","author":"Liaw","year":"1988","journal-title":"The American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840190203","article-title":"Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment","volume":"19","author":"Magrin","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF02904840","article-title":"Treatment of HBsAg-positive chronic hepatitis with corticosteroids and\/or azathioprine. A prospective study","volume":"13","author":"Manzillo","year":"1983","journal-title":"Ricerca in Clinica e in Labarotorio"},{"issue":"7806","key":"10.1002\/14651858.CD002904.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray","year":"1973","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD002904.pub2-BIB0029|cit29","first-page":"396","article-title":"Preospective randomised controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon-alpha alone in patinets with chronic active hepatitis B","volume":"1","author":"Niederau","year":"1992","journal-title":"The European Journal of Medicine"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.34.2_Suppl.S91","article-title":"A controlled trial of high dose of interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B","volume":"34 Suppl (2)","author":"Perez","year":"1993","journal-title":"Gut"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0031|cit31","first-page":"791","article-title":"Chronic posttranfusion non-A, non-B hepatitis and autoimmune chronic active hepatitis-aspects on treatment, prognosis and relation to hepatitis C virus","volume":"79","author":"Schvarcz","year":"1991","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.1840070328","article-title":"Effects of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis","volume":"7","author":"Sj\u00f6gren","year":"1987","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0033|cit33","first-page":"130","article-title":"A controlled trial of steroid therapy in massive hepatic necrosis","volume":"62","author":"Ware","year":"1974","journal-title":"The American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0016-5085(81)90707-1","article-title":"A prospective trial of steroid therapy in severe viral hepatitis. The prognostic significance of bridging necrosis","volume":"80","author":"Ware","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/gut.23.8.650","article-title":"Effects of prednisolone\/azathioprine in chronic hepatitis B viral infection","volume":"23","author":"Weller","year":"1982","journal-title":"Gut"},{"issue":"6","key":"10.1002\/14651858.CD002904.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.1840020605","article-title":"Prednisole in HBsAg-positive chronic active hepatitis: histologic evaluation in a controlled prospective study","volume":"2","author":"Wu","year":"1982","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD002904.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0168-8278(05)80143-6","article-title":"A randomised, controlled clinical trial of interferon alpa 2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B","volume":"20","author":"Zarski","year":"1994","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0038|cit38","first-page":"903","article-title":"Hepatitis C","volume-title":"Oxfort Textbook of Clinical Hepatology","volume":"1","author":"Alberti","year":"1999"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0168-8278(03)00008-4","article-title":"Management of hepatitis C","volume":"38 Suppl (1)","author":"Alberti","year":"2003","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM198911303212202","article-title":"Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis","volume":"321","author":"Alter","year":"1989","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002904.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD002904.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1440-1746.1999.01896.x","article-title":"Low-titre auto-antibodies predict autoimmune disease during interferon-alfa treatment of chronic hepatitis C","volume":"14","author":"Bell","year":"1999","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1-2","key":"10.1002\/14651858.CD002904.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0041-1345(00)02507-0","article-title":"Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial","volume":"33","author":"Belli","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/gut.37.4.449","article-title":"The management of chronic hepatitis C virus infection","volume":"37","author":"Booth","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"129A","DOI":"10.1016\/S0168-8278(03)80709-2","article-title":"Interferon alpha plus ribavirin versus interferon alpha for chronic hepatitis C - an updated systematic Cochrane review","volume":"38 Suppl (2)","author":"Brok","year":"2003","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-8278(96)80009-2","article-title":"Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies","volume":"24","author":"Calleja","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0047|cit47","unstructured":"Deeks JJ Bradburn MJ Localio R Berlin J Much ado about nothing: meta-analysis for rare events [abstract] Proceedings of 2nd symposium on systematic reviews: beyond the basics. www.ihs.ox.ac.uk\/csm\/talks.html#p23 (accessed 16\/2 2004) 1999 23"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.510260720","article-title":"Side effects of alpha interferon in chronic hepatitis C","volume":"26 Suppl (1)","author":"Dusheiko","year":"1997","journal-title":"Hepatology"},{"issue":"7109","key":"10.1002\/14651858.CD002904.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple grapical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD002904.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.1840360621","article-title":"Extrahepatic manifestations of hepatitis C among United States male veterans","volume":"36","author":"El-Serag","year":"2003","journal-title":"Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD002904.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3748\/wjg.v9.i7.1487","article-title":"Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy","volume":"9","author":"Fabbri","year":"2003","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD002904.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2036.2003.01681.x","article-title":"Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy","volume":"18","author":"Fabris","year":"2003","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"Journal of Clinical Pathology"},{"issue":"7-8","key":"10.1002\/14651858.CD002904.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/S0041-1345(01)02367-3","article-title":"Study of simulect-based, steroid-free immunosuppressive regimen in HCV de novo liver transplant patients: preliminary results","volume":"33","author":"Filipponi","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"13","key":"10.1002\/14651858.CD002904.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM197603252941301","article-title":"Steroid therapy in severe viral hepatitis. A double-blind, randomized trial of methyl-prednisolone versus placebo","volume":"294","author":"Gregory","year":"1976","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0058|cit58","article-title":"Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis","author":"G\u00f8tzsche","year":"2002","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2710.2000.00284.x","article-title":"Is enough attention being given to the adverse effects of corticosteroids therapy","volume":"25","author":"Hougardy","year":"2000","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0060|cit60","volume-title":"Code of Federal Regulations & International Conference on Harmonization Guidelines","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0061|cit61","first-page":"528","article-title":"Adverse events in short-term steroid therapy. Which adverse events can be expected during daily administration of 20 to 40 mg prednisolone for a period of 1-3 weeks","volume":"162","author":"Jarlb\u00e6k","year":"2000","journal-title":"Ugeskraeft for Laeger"},{"issue":"7303","key":"10.1002\/14651858.CD002904.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"British Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD002904.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0064|cit64","article-title":"Ribavirin with or without alpha interferon for chronic hepatitis C","author":"Kjaergard","year":"2003","journal-title":"The Cochrane Library"},{"issue":"14","key":"10.1002\/14651858.CD002904.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199604043341406","article-title":"Autoimmune hepatitis [see comments]","volume":"334","author":"Krawitt","year":"1996","journal-title":"The New England Journal of Medicine"},{"issue":"4902","key":"10.1002\/14651858.CD002904.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo","year":"1989","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD002904.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8553(21)00054-6","article-title":"Treatment of chronic hepatitis","volume":"21","author":"Lambiase","year":"1992","journal-title":"Gastroenterology Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0192-0561(99)00005-3","article-title":"Effects of corticosteroids on HCV infection","volume":"21","author":"Magy","year":"1999","journal-title":"International Journal of Immunopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0069|cit69","article-title":"Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B","author":"Mellerup","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0071|cit71","article-title":"Interferon for acute hepatitis C","author":"Myers","year":"2003","journal-title":"The Cochrane Library"},{"issue":"5","key":"10.1002\/14651858.CD002904.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schultz","year":"1995","journal-title":"The Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD002904.pub2-BIB0073|cit73","first-page":"300","article-title":"Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients","volume":"91","author":"Thiele","year":"1996","journal-title":"The American Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD002904.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/00007890-199905270-00003","article-title":"A pilot study on the safety of immunosuppression without prednisone after liver transplantation","volume":"67","author":"Tisone","year":"1999","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD002904.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0676.1986.tb01070.x","article-title":"Steroids in chronic B hepatitis. A randomized, double-blind, multinational trial on the effect of low-dose, long-term treatment on survival. A trial group of the European Association for the Study of the Liver","volume":"6","author":"Tygstrup","year":"1986","journal-title":"Liver"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0076|cit76","unstructured":"WHO Fact sheet N 164 http:\/\/www.who.int\/inf-fs\/en\/fact164.html"},{"key":"10.1002\/14651858.CD002904.pub2-BIB0077|cit77","unstructured":"WHO Press Release Hepatitis C: 170 million affected worldwide and still no vaccine http:\/\/www.who.int\/emc\/diseases\/hepatiti\/index.html"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002904.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:32:14Z","timestamp":1776069134000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002904.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,4,19]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002904.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,19]]}}}